© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Doxorubicin Hydrochloride belongs to the class of anthracycline antibiotics and serves as a cornerstone drug in modern chemotherapy regimens. This compound carries a reputation not just in pharmaceutical circles but throughout healthcare spaces focused on oncology. Its value stems from a potent ability to interfere with DNA replication, which in turn targets and kills rapidly dividing cancer cells. The story of doxorubicin is a testament to what happens when rigorous lab work meets a pressing medical need. Its journey from soil microbe cultures to clinical applications highlights an enduring blend of science and purpose.
Doxorubicin Hydrochloride enters the supply chain primarily in solid forms, most often presented as a fine orange-red powder or lyophilized crystalline substance. Transparency in raw materials helps ensure consistency and safety in both storage and delivery. Some products arrive in the form of flakes, while occasionally one may find pearls or tablet formulations suitable for specific research or compounding demands. Pharmacies and laboratories sometimes receive it as a liquid solution—usually a measured volume stored in clear glass vials. Each physical form arises from the compound’s solubility profile, flow properties, and stability requirements. This physical versatility supports its administration in diverse clinical settings, including intravenous solutions that require solubility and biocompatibility.
The molecular structure of doxorubicin hydrochloride consists of a tetracyclic quinone-containing core, bearing the chemical formula C27H29NO11·HCl. Its dense molecular arrangement features an anthracycline chromophore, which not only delivers therapeutic properties but also gives the substance its striking reddish color. Understanding this structure—four fused rings bound to a daunosamine sugar and an array of hydroxyl and methoxy groups—proves essential for researchers and clinicians alike. Tiny changes within this structure can alter the way the molecule interacts with DNA or enzymes in cancer cells, impacting clinical efficacy and patient safety.
Doxorubicin hydrochloride typically appears as a crystalline solid. Its density, close to 1.7 g/cm3, reflects the tightly packed molecular crystal lattice that forms under standard atmospheric conditions. The substance melts at temperatures between 200°C and 205°C, though it decomposes before reaching a boiling point; sustained high temperatures cause the loss of chemical activity essential for medical use. As a powder, it clings together due to strong intermolecular forces. In a solution, doxorubicin hydrochloride dissolves readily in water, where it forms a distinct red-orange liquid. This visual cue, while striking, also acts as a practical identifier in the lab when differentiating from other chemotherapeutic agents.
Across the raw materials market, strict specifications help define the purity and quality of doxorubicin hydrochloride. Pharmaceutical producers expect impurity levels—measured by advanced chromatographic techniques—to remain minimal, typically below the 1% threshold for known analogs and degradation products. Water content and residual solvents draw similar scrutiny; assurance of stability and sterility reduces the risks for end users. When it comes to international shipping and import/export documentation, the product carries the HS Code 2941.90, classifying it within the organic chemical compounds category commonly used for antibiotics and chemotherapeutics. Border authorities and commercial partners rely on this code for accurate tracking in global trade flows.
Safety dominates every stage of handling doxorubicin hydrochloride. The compound shows recognized cytotoxic and mutagenic properties; direct exposure to the eyes, skin, or mucous membranes must be avoided. Inhalation risks, though lower in solid or powder form compared to volatile chemicals, pose genuine concerns for laboratory and pharmacy staff, especially during compounding or when managing spills. Most facilities maintain engineering controls—such as ventilated pharmacy hoods and personal protective equipment—to prevent accidental contact. Accidental leaks, even as piquant orange-red droplets or scattered powder, call for immediate cleanup by teams versed in hazardous drug protocols. Waste generated from patient use or preparation goes through double-bagged, locked containers before incineration, reflecting the compound’s categorization as both hazardous and harmful.
Handling the bulk raw material requires more than just standard good manufacturing practice. Specialized industries invest in regular staff training, integrating lessons learned from occupational studies on antineoplastic agents into everyday protocols. Implementing periodic air and surface monitoring helps uncover latent contamination, especially in high-throughput hospital pharmacies. Technological developments like closed-system transfer devices and prefilled dose syringes have reduced direct handling risks and improved dose accuracy. To safeguard the local environment, regular audits confirm proper waste segregation and disposal practices. Closer industry collaboration, where manufacturers share updated hazard data and real-time shipment quality reports, protects everyone along the supply chain—workers, end-users, and communities near production or disposal sites.
Doxorubicin hydrochloride stands at the intersection of chemistry, medicine, and public safety. As a life-saving raw material, it feeds a global supply chain that supports millions of cancer patients. Its dense scientific underpinnings show how much can depend on a well-understood molecular property or a consistently measured bulk density. Basing regulations and staff procedures on facts—whether molecular formula or HS code—builds both safety and trust. While challenges remain across manufacturing, transportation, storage, and disposal lines, persistent investment in education, process engineering, and scientific research helps reduce dangers associated with this important chemical material. The story of doxorubicin hydrochloride is one of both caution and hope: respecting its power on the bench and at the bedside defines the promise and responsibility of modern chemical sciences.
